２０２４年

2024年 業績

  1. Kakurai M, Kubota N, Harada K, Nomura T: An unusual presentation of sporotrichosis with multiple fixed papulonodular skin lesions. J Dermatol 51(4): e133-e134, 2024.04
  2. Inozume T, Fukushima S, Fukuda T, Harada K: Does dermatophytosis of the feet cause acral melanoma?. J Dermatol.51(12): e455, 2024.12
  3. Mostaghimi A, Augustin M, Harada K, Senna M, Dutronc Y, Yu G, Ball S, Murage M, Kolodsick J, Brogan Y, King B: Continued treatment with baricitinib results in meaningful scalp responses among scalp non-responder patients with eyebrow/eyelash regrowth in the first year. J Eur Acad Dermatol Venereol. 2024.11
    doi: 10.1111/jdv.20334.
  4. Takahashi C, Asakura R, Chaya A, Ota M, Harada K, Inukai T, Nakamura S, Hata Y, Watanabe-Okada E. Identification of Familial Infections Using Multilocus Microsatellite Typing in Tinea Corporis due to Microsporum canis. Med Mycol J 65(1): 1-5, 2024.
    doi: 10.3314/mmj.23-00013. PMID: 38417881.
  5. Ishibashi N, Umebayashi Y, Hirai Y: Multiple-stage MPOX Skin Eruption. Intern Med 63(10):　1523-1524, 2024.05
  6. Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Uehara N, Handa T, Tanaka M, Zhang W, Paris M, Murakami M: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. Am J Clin Dermatol 25(1):165-167, 2024.01.
  7. Tada Y, Komine M, Okubo Y, Habiro K, Tsuritani K, Morita A: Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review. J Dermatol: 51(2): 210-222, 2024.02
  8. Imafuku S, Okubo Y, Tada Y, Ohtsuki M, Colston E, Napoli A, Shao Y, Banerjee S, Morita A: Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. J Dermatol 51(3):365-379, 2024.03
  9. Gordon KB, Langley RG, Warren RB, Okubo Y, Rosmarin D, Lebwohl M, Peterson L, Madden C, de Cuyper D, Davies O, Thaçi D: Bimekizumab safety in patients with moderate to severe plaque psoriasis: Pooled data from up to three years of treatment in randomized phase 3 trials. Br J Dermatol 190(4): 477-485, 2024.03
  10. Okubo Y, Kobayashi S, Murakami M, Sano S, Kikuta N, Ouchi Y, Terui T: Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. Am J Clin Dermatol 25(5): 837-847, 2024.09
  11. Abe M, Okubo Y, Takahashi H, Endo K, Chaudhari S, Deignan C, Amouzadeh H, Hino R: Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT. Dermatol Ther (Heidelb) 14(6):1587-1597, 2024.06
  12. Choon SE, van de Kerkhof P, Gudjonsson JE, de la Cruz C, Barker J, Morita A, Romiti R, Affandi AM, Asawanonda P, Burden AD, Gonzalez C, Marrakchi S, Mowla MR, Okubo Y, Oon HH, Terui T, Tsai TF, Callis-Duffin K, Fujita H, Jo SJ, Merola J, Mrowietz U, Puig L, Thaçi D, Velásquez M, Augustin M, El Sayed M, Navarini AA, Pink A, Prinz J, Turki H, Magalhães R, Capon F, Bachelez H; IPC Pustular Psoriasis Working Group: International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council. JAMA Dermatol 160(7):758-768, 2024.07
  13. Ohtsuki M, Okubo Y, Saeki H, Igarashi A, Imafuku S, Abe M, Chaudhari S, Yaguchi M, Emoto A, Morita A: Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. J Dermatol 51(7): 950-963, 2024.07
  14. Okubo Y, Terui T, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Kimura T, Shimauchi J, Zhang W, Amouzadeh H, Murakami M: Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatol Ther (Heidelb) 14(7): 1863-1873, 2024.07
  15. Okuse M, Soekawa M, Itakura A, Kawamura T, Mburu S, Frade S, Okubo Y: Perspectives of Japanese patients on psoriatic disease burden: Results from "Psoriasis and Beyond," the Global Psoriatic Disease Survey. J Dermatol 51(10):1298-1309, 2024.10
  16. Okubo Y, Kobayashi S, Murakami M, Sano S, Kikuta N, Ouchi Y, Terui T: Authors' Reply to Wang et al., "Comment on 'Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial'". Am J Clin Dermatol 25(6):1025-1027, 2024.11
  17. Umemoto N, Kakurai M, Matsumoto T, Mizuno K, Cho O, Sugita T, Demitsu T: Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis. Microorganisms 12(1):224, 2024.01
  18. Matsumoto T, Nakamura S, Yamada A, Umemoto N, Demitsu T: Recurrence of penile tuberculid after primary surgical resection. Eur J Dermatol 34(5): 533-534, 2024.10
  19. Kanzaki M, Honda A, Sawai Y, Suda K, Suda A, Kawachi Y: Lenvatinib-induced pyoderma gangrenosum in a patient with hepatocellular carcinoma: A case report. J Dermatol 51(2): e31-e32, 2024.02
  20. Ishimatsu-Tsuji Y, Niiyama S, Irisawa R, Harada K, Kishimoto J, Tsuboi R: High migratory activity of dermal sheath cup cells associated with the clinical efficacy of autologous cell-based therapy for pattern hair loss. J Dermatol Sci 113(1): 26-33, 2024.01
  21. Numata T, Irisawa R, Mori M, Uchiyama M, Harada K: Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients. Acta Derm Venereol 22;104:adv18348, 2024.01
    doi: 10.2340/actadv.v104.18348. PMID: 38248913; PMCID: PMC10811547.
  22. Numata T, Ikutani M, Arae K, Ohno T, Okada K, Yoshimoto T, Sudo K, Suto H, Okumura K, Saito H, Harada K, Nakae S: IL-10 promotes Th17 cell differentiation by enhancing STAT1-dependent IL-6 production via IgE-stimulated mast cells. Sci Rep 14(1): 26706, 2024.11.
    doi: 10.1038/s41598-024-77929-y. PMID: 39496822; PMCID: PMC11535472.
  23. Hiruma J, Nojyo H, Harada K, Kano R: Development of treatment strategies by comparing the minimum inhibitory concentrations and minimum fungicidal concentrations of azole drugs in dermatophytes. J Dermatol 51(11):1515-1518, 2024.11
  24. Nishi W, Wakamatsu E, Machiyama H, Matsushima R, Yoshida Y, Nishikawa T, Toyota H, Furuhata M, Nishijima H, Takeuchi A, Suzuki M, Yokosuka T: Molecular Imaging of PD-1 Unveils Unknown Characteristics of PD-1 Itself by Visualizing "PD-1 Microclusters". Adv Exp Med Biol 1444: 197-205, 2024
  25. Yoshida K, Kato Y, Uchiyama A, Wakatsuki Y, Nakatsugawa M, Umebayashi Y: A case of angiosarcoma of the scalp with cardiac tamponade and hemothorax. J Dermatol 51(12): e423-e425, 2024.12
  26. Yoshida K, Numata T, Sugisaki R, Ito T, Nakai T, Takagi K, Harada K, Okubo Y: Orofacial granulomatosis associated with indium allergy and apical periodontitis. J Dermatol　51(11):　e390-e392, 2024.11
  27. 江藤隆史, 西村正幸, 西村正幸, 阿久津裕, 森康記, 濱英俊, 堺則康, 田沼弘之, 安藤浩一, 山科幸夫, 岩崎泰政, 加藤昭二, 鳥居秀嗣, 福田知雄, 帆足俊彦, 玉木毅, 佐伯秀久, 門野岳史, 木村佳史, 矢口均, 岩澤うつぎ, 高須博, 北見周: 令和4年度健保委員会会長諮問答申「令和4年度診療報酬改定の評価と対応」. 日臨皮医誌 41(4): 641-662, 2024.07
  28. 中澤亜美香, 伊藤友章, 沼田貴史, 堺則康, 大久保ゆかり, 原田和俊: 東京医科大学病院皮膚科におけるエムポックス28例の臨床症状の検討. 日臨皮医誌 41(1): 33-39, 2024.01
  29. 石黒暁寛, 柳下武士, 竹尾友宏, 柴田知之, 岩下宣彦, 大嶋雄一郎, 渡辺大輔: アトピー性皮膚炎における重症度別のデュピルマブの有効性の後方視的検討.西日本皮膚科 86(4): 411-415, 2024.08

皮膚科学分野について

皮膚科診療について

研究・業績